RESTRICTIONS AGAINST COPYING, DISTRIBUTING AND ALTERING.
Users of this website who accept and agree to the conditions specified herein may use the PDF format of the electronic publication solely for their personal, noncommercial use. Substantial or systematic reproduction is strictly prohibited. Distributing, posting, or printing the PDF files is strictly prohibited without written permission of NCRP. Use of the electronic publication constitutes agreement with these terms. Users may not modify, adapt, transform, translate or create any derivative work based on any materials included in the electronic publication or otherwise use any such materials in a manner that would infringe the copyrights therein. Each PDF file of an electronic publication will include a copyright notice and unique watermark specific to the User. The copyright notice, watermark and any other notices or disclaimers may not be removed, obscured or modified in any way.
USER WARRANTIES.
Each User warrants that it will use reasonable efforts to ensure the security and integrity of each electronic publication and will notify NCRP promptly of any unauthorized use of which they become aware. Any abuse of these terms will result in immediate cessation of access to NCRP servers and may be pursued to the fullest extent permitted under applicable laws, treaties and conventions.
CHANGE OF TERMS.
NCRP reserves the right to change, modify or otherwise alter the terms of this license without prior notice to the User.
Commentary No. 11 – Dose Limits for Individuals Who Receive Exposure from Radionuclide Therapy Patients (1995)
Product Details
Sort Title : Commentary No. 11
ISBN : ISBN 0-929600-42-8
Scientific Committee :
Executive Summary
Commentary No. 11 (1995) is a result of concern about the exposure of family members of recently discharged radionuclide therapy patients. This subject was last addressed in NCRP Report No. 37 entitled, Precautions in the Management of Patients Who Have Received Therapeutic Amounts of Radionuclides, which was published in 1972. Family members of radionuclide therapy patients would usually be considered members of the public and, therefore, would normally be limited to 1 mSv annually. However, because of the infrequent nature of the exposure and because of the benefits that accrue to a family from a patient's radiation therapy. Commentary No. 11 considers it acceptable for family members of such patients to accrue up to 5 mSv annually and that there may be specific instances when the patient's physician would allow a member of the patient's family to receive an exposure of up to 50 mSv annually. In cases when such an exposure is anticipated, training and individual monitoring should be provided. In the Commentary, there is a discussion of the different types of therapy that can be provided and of the potential exposure from each therapeutic modality. Material in an appendix provides examples of the various situations that can occur. Ultimately, the material in the Commentary is to be included in the revision on NCRP Report No. 37 which is now underway.
Excerpts and Related Information
Table of Contents
Preface
Choose Product Format
PDF
( Includes an additional 10% discount off of the hardcopy price. )
$25
Hard copy
( Includes an additional 10% discount off of the hardcopy price. )
$25
Additional information
PDF, Hard copy, Hard copy & PDF